Mitochondria in situ releasing corosolic acid enhanced antitumor effects via activating mitophagy in castration-resistant prostate cancer
Open Access
- 25 March 2026
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Corosolic acid (CA) and its derivatives have shown promise as anticancer agents, but their effectiveness against resistant cancer types remains underexplored. Organelle-targeted drug delivery is a promising approach to enhance therapeutic efficacy and reduce side effects. A mitochondria-targeted prodrug, CA-TPP, was synthesized using an esterase-responsive phenolic ester bond, which enables the in situ release of CA within the mitochondria. The therapeutic efficacy of CA-TPP was assessed both in vitro (using DU145 cells) and in vivo. RNA sequencing was employed to investigate the molecular mechanisms, particularly focusing on the PINK1/Parkin-mediated mitophagy pathway. CA-TPP significantly reduced the required treatment dose of CA by 75%, maintaining its anticancer activity. In DU145 cells, CA-TPP induced cell death through the mitochondrial apoptosis pathway. RNA sequencing revealed that CA-TPP activated apoptosis through PINK1/Parkin-mediated mitophagy. Inhibition of mitophagy via PINK1 shRNA alleviated the cytotoxic effects of CA-TPP, confirming the role of mitophagy in its mechanism. Additionally, CA-TPP treatment resulted in elevated ROS production, leading to mitochondrial apoptosis and mitophagy. The CA-TPP prodrug strategy enhances the specificity and anti-tumor effects of corosolic acid, offering a promising approach for targeted cancer therapy. This work opens new possibilities for mitochondria-targeted cancer treatments with reduced drug dosages. This study did not involve clinical trials, and thus trial registration is not applicable. The online version contains supplementary material available at 10.1186/s12967-026-08057-6.Keywords
Funding Information
- National Natural Science Foundation of China (62288102)
This publication has 39 references indexed in Scilit:
- Molecular Engineering of Plasma Membrane and Mitochondria Dual‐Targeted NIR‐II AIE Photosensitizer Evoking Synergetic Pyroptosis and ApoptosisAdvanced Materials, 2023
- Functional Materials for Subcellular Targeting Strategies in Cancer Therapy: Progress and ProspectsAdvanced Materials, 2023
- Mitochondria‐targeted atovaquone promotes anti‐lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti‐tumor immune cellsCancer Communications, 2023
- Subcellular visualization: Organelle-specific targeted drug delivery and discoveryAdvanced Drug Delivery Reviews, 2023
- Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosisCell, 2022
- Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted AtovaquoneAdvanced Science, 2022
- Mito‐Bomb: Targeting Mitochondria for Cancer TherapyAdvanced Materials, 2021
- Targeting Strategies for Tissue-Specific Drug DeliveryCell, 2020
- Prodrugs in medicinal chemistry and enzyme prodrug therapiesAdvanced Drug Delivery Reviews, 2017
- Live Cell Imaging Reveals the Dynamics of Telomerase Recruitment to TelomeresCell, 2016